Open
Do other cardiovascular drugs improve lipids more than other treatments?
Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →
Where the evidence stands
No claim has formed for this comparison yet. The trials below are registered, but none decides it.
Already under way
No registered trial that could settle this is recruiting or active.
The evidence so far
- Registered trials
- 8
- With posted results
- 2
- Published papers
- 0
Trials
- Evaluation of a POlypill and Colchicine for Risk Reduction in Patients With Established Atherosclerotic Cardiovascular Disease: The EPOCA Randomized Clinical TrialNCT06930885
- PET Imaging of Inflammation and Lipid Lowering StudyNCT04073797
- Effect of Pioglitazone on Insulin Resistance, Progression of Atherosclerosis and Clinical Course of Coronary Heart DiseaseNCT03011775 · 3 posted results
- Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)NCT06280976
- Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center StudyNCT00900146 · 1 posted result
- Effect of Colchicine in Regulating MMP-9, NOX-2, and TGF- β1 After Myocardial Infraction in Stable PatientsNCT05709509
- Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and ColchicineNCT05850091
- Prospective RandomizEd Evaluation and Management of Premature aTherosclerosisNCT07232069